Consistent with these data, it was also reported that silencing or inhibiting DGKα activity with short interfering RNA (siRNA) or small-molecule inhibitor R59022 caused increased death of glioblastoma and melanoma cells by interrupting essential oncogenic pathways [29]. This evidence concerns the gene DGKA and melanoma.